子宫腺肌病

  • 网络Adenomyosis;adenomyosis,AM;Adenomyosis of the uterus
子宫腺肌病子宫腺肌病
  1. 子宫腺肌病的MRI诊断

    MRI Diagnosis of adenomyosis

  2. 结论局部应用MTX治疗子宫腺肌病将是一个有发展前景的治疗手段。

    Conclusion Local use of MTX on the treatment of adenomyosis is a perspective method .

  3. 超声检查及血清CA(125)测定诊断子宫腺肌病的评价

    Clinical evaluation of ultrasonography and serum ca_ ( 125 ) in diagnosis of endometriosis

  4. 子宫腺肌病患者血管生成和VEGF表达的研究

    Study on Angiogenesis and Expression of VEGF in Patients with Adenomyosis of the Uterus

  5. 血清CA(125)在症状性子宫腺肌病介入治疗中的临床价值

    The Clinical Value of serum CA_ ( 125 ) in the Treatment of Symptomatic Adenomyosis by Interventional Therapy

  6. 方法回顾性分析6例子宫腺肌病患者MRI和超声检查的资料,与术后病理结果对比,评估MRI对子宫腺肌病的诊断符合率。

    Methods Twen-ty-six cases of adenomyosis of uterus diagnosed by type B ultrasonic examination and MRI were reviewed retrospectively .

  7. Integrinβ1与MMP-2在子宫腺肌病组织中的表达及其意义

    Expression and Significance of Integrin β 1 and MMP-2 in Adenomyosis

  8. 子宫腺肌病患者IL-8受体的表达

    Expression of interleukin - 8 receptors in patients with adenomyosis

  9. 目的:研究脂肪抑制序列(fatsuppression,FS)在子宫腺肌病磁共振成像(MRI)诊断中的价值。

    Objective : To study on the value of fat-suppression ( FS ) - MRI for diagnosing adenomyosis .

  10. 醋酸曲普瑞林对子宫腺肌病在位内膜细胞VEGF、TNF-α分泌的影响

    Effect of Triptorelin on release of VEGF and TNF - α in endometrial cells from patients with adenomyosis

  11. 各组卵巢内膜样囊肿大小亦明显小于治疗前A组(P<0·01),子宫腺肌病病灶大小显示治疗后B组与C组均明显小于治疗前A组(P<0·05、P<0·01)。

    Both the size of uterus in group B and C was significantly smaller than that in group A ( P < 0.05 and P < 0.01 , respectively ) .

  12. 子宫腺肌病与子宫肌瘤的临床、血清CA(125)及超声诊断的比较分析

    The comparative analysis of the clinical characteristics 、 the detection of serum CA_ ( 125 ) and B-ultrasonic diagnosis between the adenomyosis and hysteromyoma

  13. 目的探讨2D超声、CDFI对子宫腺肌病和子宫肌瘤的鉴别诊断价值。

    Objective To evaluate the value of 2D ultrasound and CDFI in the differentiation of adenomyosis and hysteromyoma .

  14. 方法对比分析33例子宫腺肌病和42例子宫肌瘤的临床、血清CA(125)及B超资料。

    Methods To compare the clinical characteristics 、 the detection of Serum CA_ ~ 125 and B-ultrasonic diagnosis in the 33 adenomyosis and 42 hysteromyoma .

  15. MMP-7及TIMP-1、Survivin、Ki-67在子宫腺肌病中的表达及临床病理学意义

    Expression of MMP-7 , TIMP-1 , Survivin and Ki-67 in Adenomyosis and Their Clinical-pathological Significance

  16. 目的探讨甲氨蝶呤(MTX)局部注射治疗子宫腺肌病的可行性。

    Objective To study the effects of Methotrexate ( MTX ) local use on adenomyosis .

  17. 口服他莫昔芬法建立ICR小鼠子宫腺肌病模型

    Establishment of an ICR Mouse Model of Adenomyosis by Oral Administration of Tamoxifen

  18. 子宫腺肌病组血清CA(125)水平明显升高,其阳性率为81.8%,显著高于子宫肌瘤组(阳性率为4.76%)(P<0.05)。

    The positive rate of detection of serum CA_ ~ 125 of two groups were 81.8 % and 4.76 % respectively and has significant difference ( P < 0.05 ) .

  19. 异位内膜中EGFR表达可能与子宫腺肌病发生机制有关。经降调节EGF/EGFR表达可望成为治疗子宫腺肌病的新途径。

    A new therapeutic approach of patient with adenomyosis may be developed based on the down regulation of EGF / EGFR expressions .

  20. 基质金属蛋白酶-2抑制蛋白RECK在子宫腺肌病中的表达

    The Expression of MMP-2 and Its Inhibitor RECK in the Adenomyosis

  21. CD105在子宫腺肌病中的表达及其临床意义

    Expression and Significance of CD 105 in Adenomyosis

  22. 结果子宫腺肌病异位内膜组织中VEGF和MVD在增生期和分泌期的表达均明显高于正常内膜(P<0.05)。

    Results The expression of VEGF and MVD in entopic endometrium with adenomyosis was significantly higher ( P < 0.05 ) than that of normal endometrium .

  23. 目的探讨各种不同体外受精(IVF)助孕方案对子宫腺肌病伴不孕症患者的疗效。

    Objective To investigate the effect of different in vitro fertilization ( IVF ) treatment protocols on infertile women with adenomyosis .

  24. 目的:本研究旨在了解子宫腺肌病(AD)与多种可疑致病因素间的联系,并对子宫腺肌病的中医体质相关性进行探讨。

    Objective : This study aimed to discuss the suspect relations between adenomyosis and its pathological factors , and discuss its interrelation with the patients ' constitution , according to the Chinese medicine .

  25. 目的探讨子宫腺肌病异位内膜组织中血管内皮生长因子(VEGF)和微血管密度(MVD)的表达。

    Objective To investigate the expression of vascular endothelial growth factor ( VEGF ) and microvascular density ( MVD ) in ectopic endometrium from patients with adenomyosis .

  26. b-FGF的表达以及血管生成对子宫腺肌病发病的影响

    Expression and significance of b-FGF and angiogenesis in uterine adenomyosis

  27. 体外培养子宫腺肌病在位内膜腺上皮中Kiss-1和乙酰肝素酶的表达及意义

    The expressions of Kiss-1 and heparanase in cultured glandular cells from eutopic endometrium in adenomyosis

  28. 结论:E-cad、MMP-2的异常表达可能与子宫腺肌病和子宫内膜癌具有相似的生物学行为,即子宫内膜细胞异位到肌层和子宫内膜癌细胞向肌层浸润性生长有关。

    Conclution : The abnormal expression of E-cad and MMP-2 might be correlated with the similar biological behavior between human adenomyosis and endometrial carcinoma .

  29. 子宫腺肌病组血清CA-125值明显升高,阳性率71.4%,子宫肌瘤组14人测定该值,无一例阳性。

    In adenomyosis the level of serum CA-125 rose evidently , the positive rate was 71.4 % ;

  30. 子宫腺肌病异位内膜腺上皮细胞的Bcl-2表达与子宫内膜异位症不同,在月经周期中也存在明显的周期性变化:增生期表达较强,分泌期表达则明显减弱甚至消失。

    The expression of Bcl-2 in ectopic glandular cells of adenomyosis showed apparent cyclic changes during the menstrual cycle . Bcl-2 was strongly expressed during the proliferative phase , but weakly expressed during the secretory phase .